Get the Stockscreener App
2.63
5.05%
-0.14
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Forecast
The Sonnet Biotherapeutics Holdings Inc (SONN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $187.82, representing a +7,041% increase from the current price of $2.63. The highest analyst price target is $196.16, and the lowest is $179.48.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month SONN Price Target
Average 261.03
(+9,825% Upside)
Is Sonnet Biotherapeutics Holdings Inc (SONN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 26.10 | Buy |
| STOCH(9,6) | 32.19 | Neutral |
| STOCHRSI(14) | 30.63 | Neutral |
| MACD(12,26) | -0.6111 | Buy |
| ADX(14) | 26.95 | Buy |
| William %R | -88.50 | Buy |
| CCI(14) | -173.06 | Sell |
Buy: 4
Sell: 1
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
2.889
Sell
|
2.9502
Sell
|
| MA20 |
3.323
Sell
|
3.3892
Sell
|
| MA50 |
4.7675
Sell
|
4.4793
Sell
|
| MA100 |
5.6112
Sell
|
5.9644
Sell
|
| MA200 |
9.6117
Sell
|
8.0257
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, SONN could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on SONN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 26.1 indicates that SONN is oversold. This indicates that SONN price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
- STOCH (Stochastic Oscillator): The STOCH value of 32.19 indicates that SONN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 30.63 indicates that SONN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 26.95 suggests a moderate trend in the market. While not exceptionally strong, it indicates that there is some directional movement occurring. You should pay attention to this trend but may also look for confirmation from other technical indicators or fundamental factors.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -173.06 indicates that SONN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term SONN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Sonnet Biotherapeutics Holdings Inc financial reports and earnings history, Sonnet Biotherapeutics Holdings Inc (SONN) stock could reach $597.87 by 2030, $340.73 by 2040 and $1,132.18 by 2050. See the projected annual prices until 2050 of the Sonnet Biotherapeutics Holdings Inc stock below:
- Sonnet Biotherapeutics Holdings Inc (SONN) is expected to reach an average price of $98.66 in 2035, with a high prediction of $112.44 and a low estimate of $98.76. This indicates an $3,651% rise from the last recorded price of $2.63.
- Sonnet Biotherapeutics Holdings Inc (SONN) stock is projected to chart a bullish course in 2040, with an average price target of $325.37, representing an $12,272% surge from its current level. The forecast ranges from a conservative $325.39 to a sky-high $340.73.
- Our analysts predict Sonnet Biotherapeutics Holdings Inc (SONN) to jump 24,985% by 2045, soaring from $659.86 to an average price of $659.73, potentially reaching $677.73. While $659.86 is the low estimate, the potential upside is significant.
- Sonnet Biotherapeutics Holdings Inc (SONN) stock is expected to climb by 2050, reaching an average of $1,104.22, a $41,885% jump from its current level. However, a wide range of estimates exists, with high and low targets of $1,132.18 and $1,106.74, respectively, highlighting the market's uncertainty.
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Year by Year Forecast
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2024
Our forecast for SONN stock price in 2024 now indicates an average price target of $283.68 with a high forecast of $566.06 and a low forecast of $1.30. The average prediction reflects an increase of +10,686% from the last recorded price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $228.92 | $179.48 | $196.16 | +8,604% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2025
Sonnet Biotherapeutics Holdings Inc Stock (SONN) is expected to reach an average price of $271.58 in 2025, with a high prediction of $342.58 and a low estimate of $200.59. This indicates an +10,226% rise from the last recorded price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $231.23 | $242.15 | $229.12 | +8,692% |
| February, 2025 | $202.51 | $200.59 | $189.47 | +7,600% |
| March, 2025 | $286.63 | $226.27 | $210.19 | +10,798% |
| April, 2025 | $274.38 | $259.43 | $340.97 | +10,333% |
| May, 2025 | $342.12 | $343.10 | $327.70 | +12,908% |
| June, 2025 | $344.34 | $341.62 | $339.16 | +12,993% |
| July, 2025 | $344.42 | $346.04 | $342.58 | +12,996% |
| August, 2025 | $342.85 | $342.05 | $340.37 | +12,936% |
| September, 2025 | $338.77 | $339.05 | $339.73 | +12,781% |
| October, 2025 | $340.81 | $340.99 | $341.07 | +12,858% |
| November, 2025 | $332.38 | $334.06 | $336.43 | +12,538% |
| December, 2025 | $322.38 | $323.68 | $326.32 | +12,158% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2026
The predicted value for Sonnet Biotherapeutics Holdings Inc (SONN) in 2026 is set at an average of $291.36. Estimates vary from a peak of $320.66 to a trough of $262.06, indicating an +10,978% surge from the present price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $316.90 | $320.54 | $320.66 | +11,949% |
| February, 2026 | $313.08 | $312.29 | $313.50 | +11,804% |
| March, 2026 | $305.09 | $305.37 | $311.09 | +11,500% |
| April, 2026 | $290.05 | $291.59 | $298.47 | +10,928% |
| May, 2026 | $287.78 | $290.58 | $293.33 | +10,842% |
| June, 2026 | $285.10 | $285.52 | $286.93 | +10,740% |
| July, 2026 | $286.02 | $284.84 | $284.62 | +10,775% |
| August, 2026 | $278.58 | $280.68 | $282.76 | +10,492% |
| September, 2026 | $274.31 | $273.51 | $276.24 | +10,330% |
| October, 2026 | $270.93 | $271.63 | $272.31 | +10,201% |
| November, 2026 | $269.23 | $270.82 | $271.47 | +10,137% |
| December, 2026 | $261.80 | $262.06 | $267.84 | +9,854% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Sonnet Biotherapeutics Holdings Inc (SONN) is $218.17, with a high forecast of $259.46 and a low forecast of $176.88. This indicates an +8,196% increase from the last price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $254.81 | $254.86 | $259.46 | +9,589% |
| February, 2027 | $247.79 | $248.33 | $252.30 | +9,322% |
| March, 2027 | $241.33 | $241.89 | $245.70 | +9,076% |
| April, 2027 | $236.13 | $236.30 | $239.33 | +8,878% |
| May, 2027 | $229.71 | $229.95 | $234.17 | +8,634% |
| June, 2027 | $221.43 | $221.48 | $227.85 | +8,320% |
| July, 2027 | $213.40 | $213.74 | $219.49 | +8,014% |
| August, 2027 | $207.32 | $207.51 | $211.34 | +7,783% |
| September, 2027 | $199.46 | $199.68 | $205.33 | +7,484% |
| October, 2027 | $192.44 | $193.10 | $197.74 | +7,217% |
| November, 2027 | $185.42 | $185.79 | $190.44 | +6,950% |
| December, 2027 | $176.63 | $176.88 | $183.21 | +6,616% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2028
In 2028, Sonnet Biotherapeutics Holdings Inc (SONN) is projected to reach an average price of $132.84, with a high projection of $174.82 and a low estimate of $90.86. This indicates an +4,951% rise from the last price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $170.94 | $171.12 | $174.82 | +6,400% |
| February, 2028 | $165.57 | $165.63 | $169.13 | +6,195% |
| March, 2028 | $156.51 | $157.08 | $163.67 | +5,851% |
| April, 2028 | $150.56 | $150.59 | $153.72 | +5,625% |
| May, 2028 | $141.85 | $142.04 | $148.78 | +5,294% |
| June, 2028 | $134.95 | $134.99 | $140.08 | +5,031% |
| July, 2028 | $128.22 | $128.28 | $133.16 | +4,775% |
| August, 2028 | $119.94 | $119.94 | $126.49 | +4,460% |
| September, 2028 | $113.37 | $113.39 | $118.17 | +4,211% |
| October, 2028 | $106.57 | $106.60 | $111.58 | +3,952% |
| November, 2028 | $97.71 | $97.79 | $104.84 | +3,615% |
| December, 2028 | $90.84 | $90.86 | $95.91 | +3,354% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2029
The 2029 price forecast for Sonnet Biotherapeutics Holdings Inc Stock (SONN) is $45.45 on average, with a high prediction of $89.06 and a low estimate of $1.8339. This represents an +1,628% increase from the previous price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $82.39 | $82.42 | $89.06 | +3,033% |
| February, 2029 | $75.55 | $75.58 | $80.61 | +2,773% |
| March, 2029 | $65.36 | $65.46 | $73.82 | +2,385% |
| April, 2029 | $59.76 | $59.90 | $63.57 | +2,172% |
| May, 2029 | $52.29 | $52.29 | $57.75 | +1,888% |
| June, 2029 | $45.14 | $45.20 | $50.30 | +1,616% |
| July, 2029 | $37.97 | $38.23 | $43.17 | +1,344% |
| August, 2029 | $29.65 | $29.65 | $36.19 | +1,027% |
| September, 2029 | $22.45 | $22.67 | $27.89 | +753.70% |
| October, 2029 | $13.48 | $13.67 | $20.27 | +412.50% |
| November, 2029 | $6.916 | $7.086 | $11.67 | +162.97% |
| December, 2029 | $505.88 | $1.8339 | $58.32 | +19,135% |
Sonnet Biotherapeutics Holdings Inc Stock (SONN) Price Forecast for 2030
Sonnet Biotherapeutics Holdings Inc Stock (SONN) is expected to reach an average price of $673.19 in 2030, with a high forecast of $723.82 and a low forecast of $622.56. This signifies an +25,497% surge from the last price of $2.63.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $616.07 | $622.56 | $597.87 | +23,325% |
| February, 2030 | $704.23 | $634.67 | $638.71 | +26,677% |
| March, 2030 | $694.10 | $693.70 | $679.54 | +26,292% |
| April, 2030 | $749.50 | $723.42 | $723.82 | +28,398% |
| May, 2030 | $677.69 | $699.53 | $716.93 | +25,668% |
| June, 2030 | $663.92 | $659.89 | $649.36 | +25,144% |
| July, 2030 | $654.00 | $635.40 | $645.92 | +24,767% |
| August, 2030 | $687.55 | $686.95 | $676.63 | +26,043% |
| September, 2030 | $651.95 | $670.15 | $669.95 | +24,689% |
| October, 2030 | $645.66 | $637.78 | $631.10 | +24,450% |
| November, 2030 | $708.33 | $667.70 | $653.73 | +26,833% |
| December, 2030 | $761.91 | $712.37 | $694.57 | +28,870% |
1.35%
0.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):